The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel

• Ippei Fukada ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Visualization, Writing – original draft

  * E-mail: ippei.fukada@jfcr.or.jp

  Affiliation Department of Breast Medical Oncology, Breast Oncology Center, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  http://orcid.org/0000-0001-7272-3708

  ⨯
• Yoshinori Ito,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Breast Medical Oncology, Breast Oncology Center, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Kokoro Kobayashi,

  Roles Writing – review & editing

  Affiliation Department of Breast Medical Oncology, Breast Oncology Center, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Tomoko Shibayama,

  Roles Writing – review & editing

  Affiliation Department of Breast Medical Oncology, Breast Oncology Center, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Shunji Takahashi,

  Roles Writing – review & editing

  Affiliation Department of Medical Oncology, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Rie Horii,

  Roles Writing – review & editing

  Affiliation Department of Pathology, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Futoshi Akiyama,

  Roles Writing – review & editing

  Affiliation Department of Pathology, the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Takuji Iwase,

  Roles Writing – review & editing

  Affiliation Department of Breast Surgical Oncology, Breast Oncology Center, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Shinji Ohno

  Roles Writing – review & editing

  Affiliation Breast Oncology Center, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯